AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Faqt score 799/13/2023 ![]() ![]() You’ll find them at pop up clinics, but again they’re pretty expensive and will demand a couple of hours out of your day.Īlso known as hydrodensitometry or underwater weighing. Known as the 'gold standard' due to its reliability and applicability, dual-energy X-ray absorptiometry (DEXA) is an X-ray machine designed to measure bone density that doubles up as a neat little body fat percentage scanner. Below, Silverman runs through your options, varying in reliability.įor the best results, take the tests first thing in the morning on an empty stomach, don’t drink water or participate in strenuous exercise beforehand – yes, including running for the bus – and re-test in the exact same conditions every three to four weeks. These days there are a wealth of different tools you can use to measure your body fat. Unknown // Getty Images How to Measure Body Fat Percentageįirst you need to accurately measure what you’re working with. Whereas the American Council on Exercise ( ACE) recommends for men: So, what is a healthy body fat percentage? Nuffield health recommends for men: Vascular, lean muscle is one thing, a shrink-wrapped human is another. 'The value often cited for healthy men with normal BMIs is 15 per cent,' says Heymsfield. The Royal College of Nursing lists 8-20 per cent for 20-39 year old men, rising to 11-22 per cent if you’re between 40 and 59. 'There are reports of deaths at these levels.' 'Pushing your body fat percentage below five per cent is very risky,' says Heymsfield. We’re certainly not suggesting you go that low. Attention to psychosocial health is also essential both during and after completion of active treatment to optimize QOL outcomes.Then there’s the flip side of the coin: the gym-goers who strive to get their score as low as possible, aiming for that worrying point where ripped meets translucent. In multivariable analyses, non-white race (p=0.02) and ER/PgR+ status (p=0.05) remained associated with worse QOL mastectomy was borderline significant (p=0.06).Ĭonclusions: Among women participating in a contemporary adjuvant BC chemotherapy trial, a substantial proportion of survivors experience symptoms that may be amenable to intervention, including referral to physical rehabilitation, especially among pts undergoing more extensive surgery. In univariate analyses, non-white race (p=0.03), ER/PgR+ status (p=0.04) and mastectomy as primary surgery (p=0.01) were significantly associated with worse QOL (lower FACT B+G scores). Compared to BCS pts, mastectomy pts had lower average EQ5D-3L scores 0.80 vs. A higher proportion of mastectomy pts reported problems with usual activities compared to BCS pts (Table). Using EQ-5D-3L, over half of the pts (58%) reported at least some pain/discomfort 38% symptoms of anxiety/depression. There were no differences in QOL between bev vs placebo treatment arms (EQ-5D-3L Index Score p=0.65 FACT B+G Score p=0.23) at 18 mos so groups were combined. Median age at enrollment was 52 (range: 25-76) years. At enrollment, 57% (266/465) had a mastectomy 43% (199/465) breast conserving surgery (BCS). Results: Patient reported outcomes at 18 mos were available from 89.6% (465/519) pts. Multivariable regression was used to evaluate factors in addition to primary surgery at enrollment (age, race, ER/PgR status, tumor size, nodal status) associated with overall FACT score at 18 mos. Fisher's exact test compared categorical and Wilcoxon rank sum test compared continuous variables between subgroups. Functional/psychosocial QOL domains were assessed by the EQ-5D-3L and the FACT B+G. Telephone based surveys were administered to all pts enrolled between 01/Jan/10 and 08/Jun/10 as part of a Decision-Making/QOL component until 18 mos post enrollment. Methods: The ECOG-ACRIN protocol E5103 was a phase III trial that randomized BC patients (pts) who had undergone definitive BC surgery to receive adjuvant doxorubicin, cyclophosphamide, and paclitaxel with either bevacizumab (bev) or placebo. We sought to describe the impact of BC surgery on QOL among breast cancer survivors followed in a large randomized trial. Background: Breast cancer (BC) treatment, including surgery, can impact not only short-term health outcomes but may also affect longer term health-related and psychosocial quality of life (QOL). ![]()
0 Comments
Read More
Leave a Reply. |